ALMS

Conviction 93HealthcareScan · Mon, Aug 10, 2026

ALMS$27.53-0.27%

ResistanceSupportVol 14Insider sell

Vol MA14 967.35K

May 11May 28Jun 16Jul 6Jul 23Aug 10

ALUMIS INC.PHARMACEUTICAL PREPARATIONSwww.alumis.com ↗

Price27.53

Change-0.27%

Gap-0.49%

Rel volume1.64×

Avg volume1.04M

Avg $ vol29M

SMA 2027.80

SMA 5025.61

SMA 20020.65

Price vs 50+7.50%

Price vs 200+33.30%

MA stackbullish

50/200 cross—

Supertrendup · 24.86

RSI (14)51

MACD hist-0.20

MACD cross—

Stoch %K / %D52 / 51

ADX (14)20

+DI / −DI20 / 17

RSI divergence—

MACD divergence—

ATR %+6.19%

ADR %6.10%

52w high30.30

52w low3.95

From 52w high-9.16%

Above 52w low+596.84%

New 52w highNo

SqueezeOn · 3d

Bollinger width13.37%

%B0.42

Donchian pos46.37%

Donchian high30.11

Donchian low25.29

AVWAP (52w high)28.15

vs AVWAP high-2.22%

AVWAP (52w low)20.18

vs AVWAP low+36.40%

OBV trendDown

Chaikin MF (20)0.09

Today vs 20d1.64×

Avg vol (14d)967.35K

Avg vol (20d)1.04M

Avg $ vol (20d)29M

Market cap—

RS 3m (vs SPY)+10.46%

RS 6m (vs SPY)-9.33%

RS line new highNo

Trend template8/8

Technical rank66.3

1 week+5.38%

1 month-2.77%

3 months+16.34%

6 months+5.10%

1 year+535.68%

YTD+207.37%

P/E-9.62

P/B4.13

P/S97.33

P/FCF-6.32

EPS-2.86

Div yield—

ROE-42.91%

ROA-36.23%

Debt/Eq—

Current7.51

EV/EBITDA-5.06

Gross margin—

Net margin—

Rev growth—

EPS growth17.30%

Price target40.00

Target upside45.30%

Analyst ratingBuy

Institutional98.92%

Ent. value2.28B

Revenue1.74M

Net income-93.05M

Gross profit—

Free cash flow-370.18M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out123.43M

Employees227

ListedFri, Jun 28, 2024

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction93 / 100

Pattern quality—

Tech rank66.3 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance30.73

Support25.39

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ALMS

All disclosures →

No recent disclosed trades by Congress in ALMS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ALMS · 2 buys · 8 sells

Insider	Side	Shares	Value	Traded	Filed
Hardiman Roy C. Chief Business & Strategy Ofcr · Common Stock · 2026-08-03	Sell	2.69K	$71K	2026-08-03	2026-08-05
Schroer John R. Chief Financial Officer · Common Stock · 2026-08-03	Sell	3.28K	$87K	2026-08-03	2026-08-05
Goldstein David M Chief Scientific Officer · Common Stock · 2026-08-03	Sell	2.6K	$68K	2026-08-03	2026-08-05
Drappa Jorn Chief Medical Officer · Common Stock · 2026-08-03	Sell	2.45K	$65K	2026-08-03	2026-08-05
Bradley Mark Christopher Chief Development Officer · Common Stock · 2026-08-03	Sell	2.57K	$68K	2026-08-03	2026-08-05
Pangali Sanam Chief Legal Officer · Common Stock · 2026-08-03	Sell	1.36K	$36K	2026-08-03	2026-08-05
Pangali Sanam Chief Legal Officer · Common Stock · 2026-07-06	Exercise	5K	$25K	2026-07-06	2026-07-08
Pangali Sanam Chief Legal Officer · Common Stock · 2026-07-06	Sell	5K	$140K	2026-07-06	2026-07-08
Pangali Sanam Chief Legal Officer · Stock Option (Right to Buy) · 2026-07-06	Exercise	5K	—	2026-07-06	2026-07-08
Drappa Jorn Chief Medical Officer · Common Stock · 2026-05-22	Exercise	11.32K	$100K	2026-05-22	2026-05-27

SEC filings

EDGAR filings in ALMS · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.